Celerion is committed to swift, exceptional clinical research through translational medicine.  Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster.  

Celerion is a Contract Research Organization (CRO) specializing in Phase I and early-phase clinical trials, including first-in-human (FIH) studies, bioequivalence/bioavailability studies, and specialized populations research. We partner with pharmaceutical and biotechnology sponsors to safely and efficiently advance new therapies through clinical testing.

Celerion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, genetic information, marital status, qualified protected veteran status, or disability.